Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy

 Abstract

Pathological phenotypes in inclusion body myopathy (IBM) associated with Paget disease of the bone (PDB), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) (IBMPFD/ALS) include defective autophagosome and endosome maturation that result in vacuolation, weakness and muscle atrophy. The link between autophagy and IBMPFD/ALS pathobiology has been poorly understood. We examined the AKT-FOXO3 and MTOR pathways to characterize the regulation of autophagy in IBMPFD/ALS mouse muscle. We identified a defect in MTOR signaling that results in enhanced autophagosome biogenesis. Modulating MTOR signaling may therefore be a viable therapeutic target in IBMPFD/ALS.

 Related Article:

JK Ching, SV Elizabeth, JS Ju, C Lusk, SK Pittman, CC Weihl. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum Mol Genet 2013; 22: 1167- 79.
PMID: 23250913 DOI: 10.1093/hmg/dds524

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
799 - 800
doi
10.4161/auto.23958
Type
Autophagic Punctum
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy